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The basement membrane zone (BMZ) of human skin i s 
a complex structure which contains several well-defined 
components including bullous pemphigoid antigen, lam-
inin, type IV collagen, and proteoglycan. Characteriza-
tion of additional basement membrane (BM) constituents 
has been limited by their relative inaccessibility, insol-
ubility, and low tissue concentration. We have produced 
a murine monoclonal antibody that has enabled us to 
define a unique constituent of the BMZ of human strati-
fied squamous epithelia. The monoclonal antibody (KF-
1) was raised by standard techniques using suction blis-
ter-derived trypsinized human epidermal ce lls as the 
antigen. Indirect immunofluorescence and immunope-
roxidase staining of human and rhesus monkey tissues 
with KF-1 produced linear BMZ staining of stratifie d 
squamous epithelia. Glandular and vascular BMs were 
not stained. Immunoelectron microscopic studies of nor-
mal human skin and esophagus showed specific binding 
of KF-1 to the lamina densa of the BMZ, a localization 
identical to that of type IV collagen. However, unlike 
type IV collagen, which is not species specific and is 
found in all BMs, the antigen defined by KF-1 is colla-
genase-resistant and is specific for primate stratified 
squamous epithelia. These findings confirm the existence 
of regional variation in BM composition, and demon-
strate for the first time that the lamina dens a of stratified 
squamous epithelial BMs contains a constituent other 
than type IV collagen. 
Basement membranes (BMs) are extracellular matrices found 
at th e junctions between epithelial cells and connective tissues, 
a nd have important functions in cell differentiation, filtration 
of macromolecules, and the maintenance of tissue architecture 
[1,2). While the ultrastructure of BMs has been well character-
ized [2,3], their biochemical composition has only recently 
become the subject of intensive investigation. Certa in BM 
constituents including type IV collagen [2,4], glycosaminogly-
cans (heparan sulfate proteoglycan) [5,6], a nd the noncollage-
nous glycoproteins laminin [7,8] and fibron ectin [9,10] are pre-
sent in all BMs [11,12] and are neither tissue- nor species-
specific. Other BM components defined by autoantibodies in 
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the serum of patients with bullous pemphigoid [13,14] and 
Goodpastme's syndrome [15] h ave a more r estricted tissue 
dis tribution, but are similarly not species-specific. Since spon-
taneously occurring autoantibodies have been used to investi-
gate BM composition, we sought to determine wheth er experi-
m entally produced monoclonal antibodies might prove useful 
in the identification of fmth er BM constituents. We report h ere 
on the production of a monoclonal a ntibody (KF-1) which has 
defined a unique collagenase-rfsis tant primate-specific antigen 
restricted to BMs of stratified squamous epithelia and localized 
by immunoelectron microscopy to the lamina densa. 
MATERIALS AND METHODS 
Preparation. of M onoclonal KF-1 Antibody 
The KF-1 antibody was developed using a BALB/ c mouse sensitized 
subcutaneously with a suspension of suction blister-derived trypsinized 
human epidermal cells (6 X 10" viable cells) (16,17]. The mouse received 
an in travenous injection of epidermal ce Lls 3 months later, and was 
sacrificed afte r 3 days. Spleen cells from the sensitized mouse were 
fused in the presence of polyethylene glycol with a non-immunoglobu-
lin-producing mouse myeloma cell line (SP 2/0-Ag 14) [18,19] and 
hybrid cells were isolated by growth in selective HAT medium. Follow-
ing identification of the BM specificity of KF-1 using indirect immu-
nofluorescence with cryostat sections of normal human ski11 as sub-
strate, the hybrid cells producing this antibody were cloned by limiting 
dilution. The monoclonal KF-1 antibody was haJ-vested from the ascitic 
fluid of pristane-primed BALB/c mice injected i.p. with the hybrid 
cells. Control ascitic fluid was obtained from mice inj ected i.p. with the 
parent SP 2/0-Ag 14 cells. 
Immunofluorescence Studies 
Six-micron cyrostat sections of unfixed normal human, rhesus mon-
key, mouse, rat, guinea pig, and chicken tissues, together wi th sections 
of the BM matrix-secreting-murine EHS tumor [20] were stained by an 
indirect immunofluorescence technique with optimal dilutions of KF-1 
followed by fluoresceinated rabbit antimouse antibodies. Human skin 
was obtained from volunteers and other normal human tissues were 
obtained at autopsy. Sections of normal human skin and kidney were 
pretreated with testicular hyalw·onidase 2% w/ v at 37°C, 4 M guanidine, 
1 M sodium chloride, or 1% acetic acid in order to determine the effects 
of these agents on subsequent basement membrane zone (BMZ) tain-
ing with KF-1. In addition, sections of normal human skin were treated 
with bacterial co Llagenase (Advance Biofactures Co., Lynbrook, New 
York) 2,400 U/ ml at 37"C for 1 h before incubation with optimal 
dilutions of KF-1 or affinity-purified antibodies to type IV collagen. 
Indirect immunofluorescence studies with KF-1 were also performed 
on the following cells grown on glass coverslips and fixed in -20°C 
methanol for 10 min and -20°C acetone for 10 s [21]: human epidermal 
cells derived from neonatal foreskins by trypsinization and cu ltured on 
ra t-tail tendon collagen [22] or on a feeder layer of lethally irradiated 
murine 3T3 fibroblasts [23], human skin fibroblast cell lines CCD-28Sk 
and CCD-48Sk (American Type Cul ture Collection, Rockville, Mary-
land), human A-431 epidermoid carcinoma cell line [24], human base-
ment membrane component-secreting HT-1080 tumor cell line [25], 




Blocks of fresh unfixed normal human skin and esophagus were 
incubated at 4 oc in phosphate-buffered saline (PB ), pH 7.4, contain-
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ing 10% w/v glycerin for 2 h and were then subjected to s low freezing 
in O .C.T. (Miles Laboratories Inc., Naperville, Illinois) at -20°C. S ix-
and 16-fJ.m cryostat sections were pt·eincubated for 30 min with a 1:5 
dilu tion of norma l rabbit serum, and were then incubated sequentia lly 
with optima l dilu t ions (in PBS conta ining 1% w/ v bovine serum a lbu-
min) of (I) KF-1 , (2) rabbit antimouse lgG, and (3) horserad ish perox-
idase-conjugated staphylococcal protein A (K i1·kegaard & Perry Labo-
ratories Inc. , Gaithersbu rg, Mru·yland). Control sections we t·e incubated 
with asc itic fluid from mice injected i.p. with SP 2/ 0 Ag-14 ce lls (18]. 
Sections were wa hed for 15 min in 3 changes of PBS between succes-
sive incubations. After a fin al wash, bound conjugate was detected 
histochemically by incubation with 3'3' -diaminobenzidine and hydrogen 
peroxide (27). 
S ix- micron sections were mou nted in buffered glycerol under a 
coverslip and examined and photographed. Sixteen-micron sections 
were fixed in osmium tetroxide and embedded in E pon. Ultrathin 
sections were coun te rstained with lead citra te and examined using a 
P hilips 400 transmission e lectron microscope. 
ELISA Assay 
T he presence or absence of binding of KF-1 to types I, II, III , IV, or 
V collagen (obta ined from rat ski n (28], rat chonru·osarcoma (29], 
human skin (30], EHS mouse tumor (31], and huma n placenta (32], 
respectively), Ascaris cut icle collagen (the gift of Ms. C. S ullivan, 
National Institu te of Dental Research), chick fibroblast f'ibronectin 
(33], laminin [7], and heparan sulfate proteoglycan [6] (isolated from 
murine E HS tumor) was investigated in an ELISA assay. 
RESULTS 
Immunofluorescence and Imm.unoperoxidase Studies 
Indirect immunofluorescence taining of unfixed normal hu-
man skin with KF-1 produced a linear band of flu orescence at 
the dermal-epidermal and hair follicle BMZ. Glandular and 
vascular BMs were not stained. BMZ fluorescence was absent 
from sections incubated with control ascit ic fluid. Indirect im-
munoperoxidase staining of normal human skin using peroxi-
dase-conjugated staphylococcal protein A confirmed the spe-
cific binding of KF-1 to the BMZ (Fig 1) . KF-1 was localized 
ultrastructurally to the lamina densa (Fig 2). Additional indirect 
immunofluorescence studies with KF-1 demonstrated linear 
BMZ fluorescence in sections of human lip, vaginal mucosa, 
tongue, and upper esophagus but not in sections of lung, liver, 
gallbladder, stomach, small intestine, rectum, kidney, ureter , 
bladder, or placenta. Although it exhibi ted cross-reactivity with 
rhesus monkey tissues, KF-1 did not bind to mouse, rat, guinea 
pig, or chicken tissues. 
In order to determine whether the failw-e of the KF-1 anti-
body to bind to BMs in the majority of t issues was due to the 
inaccessibility of the antigen, we pretreated sections of human 
kidney with testicular hyaluronidase, 4 M guanidine, 1 M sodium 
chloride, or 1% acetic acid in attempts to expose new a ntigenic 
sites. Use of these agents did not result in subsequent binding 
ofKF-1 to the kidney sections, while KF-1 staining of the BMZ 
of skin sections treated in the a bove manner remained unal-
tered. Pretreatment of skin sections with bacterial collagenase 
abolished binding of affinity-purified antibodies to type IV 
FIG 1. Immunoperoxidase staining of normal human skin with KF-
1 monoclonal antibody from murine ascitic fluid . Lineru· staining along 
the BMZ is seen. X 640. 
FIG 2. Ultrastructural immunoperoxidase staining of normal human skin wi th KF-1 monoclona l antibody. a., The electron-dense reaction 
product following staining with KF-1 is localized to the lamina densa region of the BMZ. b, No reaction product is seen after incubation with 
con t rol ascitic fluid. (E =epidermis; XXX= lamina Iucida; LD = lamina densa; D =dermis). Bars= 0.25 J.Lm. 
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collagen, but did not diminish subsequent BMZ staining with 
KF -1 in indirect immunofluorescence studies. 
KF-1 did not stain sections of the murine basement mem-
brane matrix-secreting EHS tumor, nor did it stain human 
epidermal cells, human fibroblasts, human A-431 and HT-1080 
tumor cell lines, or murine Pam 212 cells in culture. 
ELISA Assay 
KF-1 did not bind in an ELISA assay to types I, II, III, IV, or 
V collagen, Ascaris cuticle collagen, chick fibroblast fibronectin, 
laminin, or heparan sulfate proteoglycan. 
DISCUSSION 
Immunofluorescence and immunoperoxidase studies showed 
specific binding of the KF-1 monoclonal antibody to the BMZ 
of primate stratified squamous epithelia. The ultrastructural 
localization of the antigen defined by KF-1 is identical to that 
of type IV collagen, the only currently recognized constituent 
of the lamina densa of skin BMZ [34]. It is therefore possible 
that the KF-1 antibody is detecting a posttranslational modifi-
cation of type IV collagen specific to stratified squamous epi-
thelia. This possibility is unlikely, however, as the antigenicity 
of the KF-1 antigen was retained following pretreatment of skin 
sections with bacterial collagenase which abolished subsequent 
binding of affinity-purified antibodies to type IV collagen. 
The restricted tissue and species distribution of the antigen 
defined by KF-1 and its collagenase resistance argue against its 
being a component of type IV collagen. Bullous pemphigoid 
antigen [14] is the only known BM constituent that has a 
distribution restricted to stratified squamous epithelia [13]. 
However, unlike the antigen defined by KF-1, bullous pemphi-
goid antigen has been reported in BMs of all vertebrates [35] 
and is localized ultrastructurally to the lamina Iucida area of 
the BMZ [36,37]. The KF-1 monoclonal antibody therefore 
defines a newly recognized BM constituent localized to the 
lamina densa and restricted to stratified squamous epithelia. 
The antigen used to induce the formation of KF-1 was 
obtained from the roof of a suction-induced blister, and should 
therefore theoretically not have contained lamina densa anti-
genic determinants [38,39]. The most likely explanation as to 
how the KF-1 antibody, which reacts with a lamina densa BM 
constituent, was produced is that the antigenic preparation was 
contaminated by lamina densa material. Another possibility is 
that the KF-1 antigen was synthesized by the epidermal cells 
after their injection into the mouse. Although the normal in 
vivo source of the antigen is unlmown, it is probable that it is 
of epidermal cell origin. Biochemical characterization of the 
KF-1 antigen will be dependent on the identification of a human 
cell culture system capable of expressing the antigen in vitro. 
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Mycosis fungoides (MF) and Sezary syndrome (SS) are 
uncommon neoplasms of the lymphoreticular system 
with distinct clinical, histologic, and immunologic fea~ 
tures. Based on the thymus~derived nature of the neo~ 
plastic cells, MF and SS are both classified as cutaneous 
T~cell lymphoma. While substantially greater under~ 
standing of MF and SS has been made possible, the exact 
mechanism for the initiation of either disease is still 
unknown. The possible involvement of environmental 
factors as well as viral etiology, i.e., retroviruses, has 
been suggested. In order to investigate the possible role 
of HLA-associated variations in genetic susceptibility, 
74 patients with histologically documented MF were 
typed for HLA-A, -B, and -C antigens. Half of these 
patients were also typed for HLA-DR antigens. An in-
crease in DR5 was the only statistically significant de-
viation in HLA antigen frequencies in these patients 
(53% in MF as compared with 20% in controls). An in-
creased frequency of HLA-DR5 has also been associated 
with scleroderma and juvenile rheumatoid arthritis both 
of which have immunologic alterations. Also HLA-DR5 
has been associated with renal cell carcinoma and Ka-
posi's sarcoma. The association ofMF with DR5 suggests 
that some individuals with the DR5 antigen may be at 
higher risk for virally initiated and/or neoplastic dis-
eases possibly through an HLA-linked defect in the im-
mune system. 
Mycosis fungoides (MF) is an uncommon neoplasm of the 
lymphoreticular system with clinical, histologic, and immuno-
logic features distinct from other forms of lymphoma. Substan-
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tially greater understanding of MF and Sezru·y syndrome (SS) 
was made possible by the recent advances in the area of 
lymphocyte biology which have permitted accurate chru·acter-
ization of the neoplastic cells of MF and SS as helper type T 
lymphocyte, thus allowing classification of these disorders as 
cutaneous T-celllymphoma (CTCL) [1]. The classical form of 
the disease manifests initially in the skin and pmsues a slowly 
progressive course with eventual involvement of the internal 
organs resulting in the death of the patient. While the cause of 
CTCL remains unclear, several investigators have suggested a 
role for various environmental factors in the pathogenesis of 
the disease. Industrial exposure has been linked to the disease 
at a statistically significant level by Cohen [2]. Further, Fisch-
mann et al, found that 91% of MF patients had had multiple 
exposure to potentially cru·cinogenic chemicals [3]. R ecently 
Poiesz et al, implicated viral infection as another possible 
contributory factor by their finding of type C retrovirus parti-
cles in the cultmed lymphocytes of MF patients [ 4]. 
Aside from the environmental factors and the possible role of 
retroviruses, a genetic susceptibility has also been suggested as 
playing a part in the pathogenesis of MF. While no character-
izable mode of inheritance or ethnic group predisposition has 
been observed in the disease, an increased frequency of fiTst 
degree relatives with lymphoma and leukemia has been noted 
by some authors [5]. CTCL has been reported to occm in a 
cluster pattern in some families [6]. In addition, prior studies 
have suggested an increased occurrence ofHLA antigens (Awl9, 
BB, Cw) in MF patients [7]. These observations have led us to 
further investigate the role of genetic factors as determined by 
HLA typing in the disease. Ow- results indicate that the HLA 
genetic mru·ker DR5 is significantly increased in patients with 
MF and suggest that HLA-linked genetic susceptibility factors 
may play a role in the initiation of the disease. 
MATERIALS AND METHODS 
Seventy-four Caucasian patients with histologically documented MF, 
followed since January 1977, were included in the study. The patients 
were all tested during the period of initial diagnosis and treatment, 
relatively early in the course of their disease. The patients were typed 
for all well-defined HLA-A, -B, and -C locus antigens using a large 
battery of highly selected typing sera in the standard 2-stage lympho-
cytotoxicity test. Thirty-four of the MF patients were also typed for 
DR alloantigens using the nylon column procedure [8] for emichment 
of B cells and the modified 2-stage cytotoxicity test with prolonged 
incubation times. 
